rs28361051
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001365276.2(TNXB):āc.8132T>Cā(p.Ile2711Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,612,982 control chromosomes in the GnomAD database, including 130 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001365276.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNXB | NM_001365276.2 | c.8132T>C | p.Ile2711Thr | missense_variant | 23/44 | ENST00000644971.2 | NP_001352205.1 | |
TNXB | NM_019105.8 | c.8132T>C | p.Ile2711Thr | missense_variant | 23/44 | NP_061978.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNXB | ENST00000644971.2 | c.8132T>C | p.Ile2711Thr | missense_variant | 23/44 | NM_001365276.2 | ENSP00000496448 | |||
TNXB | ENST00000647633.1 | c.8873T>C | p.Ile2958Thr | missense_variant | 24/45 | ENSP00000497649 | P1 | |||
TNXB | ENST00000375244.7 | c.8132T>C | p.Ile2711Thr | missense_variant | 23/44 | 5 | ENSP00000364393 |
Frequencies
GnomAD3 genomes AF: 0.00990 AC: 1507AN: 152180Hom.: 15 Cov.: 32
GnomAD3 exomes AF: 0.00993 AC: 2436AN: 245218Hom.: 25 AF XY: 0.0104 AC XY: 1393AN XY: 133814
GnomAD4 exome AF: 0.0103 AC: 15105AN: 1460684Hom.: 115 Cov.: 33 AF XY: 0.0105 AC XY: 7595AN XY: 726618
GnomAD4 genome AF: 0.00990 AC: 1507AN: 152298Hom.: 15 Cov.: 32 AF XY: 0.0109 AC XY: 814AN XY: 74466
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 25, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Mar 03, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | TNXB: BP4, BS1, BS2 - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Ehlers-Danlos syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | May 27, 2022 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at